SALE ON NOW! PROMOTIONS

Close Notification

Your cart does not contain any items

Ketamine

Bita Moghaddam

$32.99

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
MIT Press
04 May 2021
The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.

The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.

Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
By:  
Imprint:   MIT Press
Country of Publication:   United States
Dimensions:   Height: 178mm,  Width: 127mm, 
Weight:   368g
ISBN:   9780262542241
ISBN 10:   0262542242
Series:   MIT Press Essential Knowledge
Pages:   136
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active
Series Foreword ix Preface xi 1 The Molecule Ketamine 1 2 Uses of Ketamine 17 3 Neuroscience of Ketamine 31 4 Ketamine as an Antidepressant 65 5 How Does Ketamine Produce Antidepressant Effects? 101 6 Safety Concerns with Ketamine and Esketamine 121 7 Where Do We Go from Here? 141 Acknowledgments 155 Glossary 157 Notes 161 Further Reading 177 Index 179

Bita Moghaddam is a leading researcher in the field of neuropsychopharmacology. She is Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health and Science University in Portland.

See Inside

See Also